Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: S$0.15 M
• Last 3 months FTD volume: S$1.63 M
• Last year FTD volume: S$1.63 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	S$18.83 M	S$0.14 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	S$10.27 M	S$24.62 M	🇺🇸 USA
Neurocrine Biosciences NBIX	S$4.27 M	S$27.31 M	🇺🇸 USA
General Electric GE	S$0.15 B	S$1.40 B	🇺🇸 USA
Thermo Fisher Scientific TMO	S$11.3 M	S$0.20 B	🇺🇸 USA
Bristol-Myers Squibb BMY	S$0.17 B	S$0.47 B	🇺🇸 USA
Pfizer PFE	S$21.73 M	S$0.33 B	🇺🇸 USA
Bio-Techne TECH	S$1.66 M	S$25.45 M	🇺🇸 USA
Sangamo Therapeutics SGMO	S$2.42 M	S$6.32 M	🇺🇸 USA
Charles River Laboratories CRL	S$10.77 M	S$55.37 M	🇺🇸 USA